News

Chin’s appointment strengthens Biomerica’s corporate governance and financial oversight as Biomerica scales commercialization efforts IRVINE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. ...
IRVINE, Calif. – Biomerica, Inc. (NASDAQ: BMRA), a biomedical technology firm specializing in advanced diagnostic and therapeutic products with a current market capitalization of $8.1 million and ...
June 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products, today ...
His successful track record includes raising $60 million for Akido Labs, indicating strong fundraising capabilities that could benefit Biomerica. Mr. Chin's appointment strengthens Biomerica's ...
IRVINE, Calif. – Biomerica, Inc. (NASDAQ: BMRA), a biomedical technology firm specializing in advanced diagnostic and therapeutic products with a current market capitalization of $8.1 million ...
June 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products ...